Kanoria Chemicals & Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
KANORICHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kanoria Chemicals reported strong Q3 FY26 results, with standalone revenue from operations rising about 42% year-on-year to Rs. 23,059 lakhs (vs Rs. 16,239 lakhs in Q3 FY25) and 9M FY26 revenue up roughly 25% to Rs. 60,800 lakhs. Standalone profit after tax for Q3 stood at Rs. 393 lakhs, a sharp turnaround from a loss of Rs. 1,970 lakhs in Q3 FY25, while 9M FY26 PAT improved to Rs. 576 lakhs from a loss of Rs. 1,851 lakhs. Consolidated revenue for 9M FY26 was Rs. 67,704 lakhs with a consolidated PAT of Rs. 8,158 lakhs, helped by a one-time gain of Rs. 9,766 lakhs from loss of control of its Swiss subsidiary APAG Holding AG (which ceased to be a subsidiary w.e.f. 31st July 2025). The company also booked an exceptional impairment of Rs. 1,064 lakhs on its remaining investment in APAG equity shares and recognized Rs. 49 lakhs of additional gratuity expense under the new Labour Codes effective 21st November 2025.
Strong top-line growth in the core Alco Chemicals business and a swing back to profitability are positive for shareholders, but a large chunk of the consolidated profit is non-recurring (gain on loss of control of APAG), so underlying earnings power from continuing operations is the key number to watch. Investors should also note the discontinued textile and solar operations, the ongoing restructuring, and the pending impact of the Finance Bill 2026 on taxes.